Atopic Dermatitis: Striving for Reliable Biomarkers

Atopic Dermatitis: Striving for Reliable Biomarkers

Atopic dermatitis (AD) is a highly heterogeneous inflammatory disease regarding both its pathophysiology and clinical manifestations. However, it is treated according to the “one-size-fits-all” approach, which may restrict response to treatment. Thus, there is an unmet need for the stratification of...

Full description

Bibliographic Details
Main Authors:	Styliani Mastraftsi, Georgia Vrioni, Michail Bakakis, Electra Nicolaidou, Dimitrios Rigopoulos, Alexander J. Stratigos, Stamatios Gregoriou
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Journal of Clinical Medicine
Subjects:	atopic dermatitis biomarkers precision medicine personalized treatment TARC/CCL17 MDC/CCL22
Online Access:	https://www.mdpi.com/2077-0383/11/16/4639

Similar Items

<i>Polyopes affinis</i> Suppressed IFN-γ- and TNF-α-Induced Inflammation in Human Keratinocytes via Down-Regulation of the NF-κB and STAT1 Pathways
by: Yuna Ha, et al.
Published: (2022-03-01)

Personalized multi-marker panel in the risk assessment of atopic dermatitis phenotypes in children
by: Volodymyr Dytiatkovskyi, et al.
Published: (2023-06-01)

High loading-dose of dupilumab resulted in rapid disease control in pediatric patients with atopic dermatitis
by: Ao Wang, et al.
Published: (2023-04-01)

Fulvic Acid Attenuates Atopic Dermatitis by Downregulating CCL17/22
by: Chenxi Wu, et al.
Published: (2023-04-01)

Analytical Performance of a Novel Latex Turbidimetric Immunoassay, “Nanopia TARC”, for TARC/CCL17 Measurement: A Retrospective Observational Study
by: Keita Yamashita, et al.
Published: (2023-09-01)

Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis
by: Sohshi Morimura, et al.
Published: (2021-02-01)

CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy
by: Joanna Bogacka, et al.
Published: (2022-12-01)

Chrysin Inhibits NF-κB-Dependent <i>CCL5</i> Transcription by Targeting IκB Kinase in the Atopic Dermatitis-Like Inflammatory Microenvironment
by: Hyunjin Yeo, et al.
Published: (2020-10-01)

CHEMOKINES CCL17 AND CCL22 IN SARCOIDOSIS
by: N. M. Lazareva, et al.
Published: (2021-10-01)

Positive association between pruritus and high expression of CCL17, CCL22 and substance P in bullous pemphigoid lesions
by: Manman ZHANG, et al.
Published: (2022-12-01)

Serum thymus and activation-regulated chemokinelevels in children with atopic dermatitis
by: Tamila Sorokman, et al.
Published: (2019-09-01)

The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review
by: Aikaterini Tsiogka, et al.
Published: (2022-07-01)

Histamine Increases Th2 Cytokine-Induced CCL18 Expression in Human M2 Macrophages
by: Susanne Mommert, et al.
Published: (2021-10-01)

Lymphoma-Associated Biomarkers Are Increased in Current Smokers in Twin Pairs Discordant for Smoking
by: Jun Wang, et al.
Published: (2021-10-01)

Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure
by: Hiroko Kasai, et al.
Published: (2021-01-01)

Translation and validation of patient-oriented eczema measure in the Greek language
by: Garyfallia Stefanou, et al.
Published: (2023-10-01)

Association of the Maternal Gut Microbiota/Metabolome with Cord Blood CCL17
by: Hiromi Tanabe, et al.
Published: (2021-08-01)

Expression of Helper and Regulatory T Cells in Atopic Dermatitis: A Meta-Analysis
by: Dao-jun Zhang, et al.
Published: (2022-04-01)

CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice
by: Aydar Khabipov, et al.
Published: (2023-05-01)

Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients
by: Lídia Sans-de San Nicolàs, et al.
Published: (2023-03-01)

The Role of Tight Junctions in Atopic Dermatitis: A Systematic Review
by: Spyridoula Katsarou, et al.
Published: (2023-02-01)

Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19
by: Zoia R. Korobova, et al.
Published: (2023-08-01)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
by: Federica Gelato, et al.
Published: (2023-03-01)

Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis
by: Dimitra Koumaki, et al.
Published: (2023-03-01)

From Allergy to Cancer—Clinical Usefulness of Eotaxins
by: Monika Zajkowska, et al.
Published: (2021-01-01)

Impressic Acid Ameliorates Atopic Dermatitis-Like Skin Lesions by Inhibiting ERK1/2-Mediated Phosphorylation of NF-κB and STAT1
by: Jae Ho Choi, et al.
Published: (2021-02-01)

Linking Dentistry and Chronic Inflammatory Autoimmune Diseases – Can Oral and Jawbone Stressors Affect Systemic Symptoms of Atopic Dermatitis? A Case Report
by: Schick F, et al.
Published: (2022-06-01)

<i>Pyropia yezoensis</i> Extract Suppresses IFN-Gamma- and TNF-Alpha-Induced Proinflammatory Chemokine Production in HaCaT Cells via the Down-Regulation of NF-κB
by: Yuna Ha, et al.
Published: (2020-04-01)

The role of heterodimer IL 17A/F in atopic dermatitis
by: Joanna Krzysiek, et al.
Published: (2022-12-01)

Prevention of Atopic Dermatitis
by: Hywel C. Williams, et al.
Published: (2020-06-01)

Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases
by: Kentaro Ohuchi, et al.
Published: (2022-12-01)

The Significance of Selected C-C Motif Chemokine Ligands in Colorectal Cancer Patients
by: Monika Zajkowska, et al.
Published: (2022-03-01)

Eotaxins and Their Receptor as Biomarkers of Colorectal Cancer
by: Monika Zajkowska, et al.
Published: (2021-06-01)

Eotaxins and Their Receptor in Colorectal Cancer—A Literature Review
by: Monika Zajkowska, et al.
Published: (2020-05-01)

Guidelines for treatment of atopic dermatitis
by: Suzana Ljubojević Hadžavdić, et al.
Published: (2022-10-01)

Atopic Dermatitis in the Elderly Population
by: Martina Maurelli, et al.
Published: (2023-12-01)

Atopic Dermatitis: Clinical Aspects and Unmet Needs
by: Fabio Lobefaro, et al.
Published: (2022-11-01)

Update on Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2019-09-01)

Insights into Early Systemic Treatment in Atopic Dermatitis: Scientific Facts and Practical Considerations
by: Efstratios Vakirlis, et al.
Published: (2024-02-01)

Skullcapflavone II Suppresses TNF-α/IFN-γ-Induced TARC, MDC, and CTSS Production in HaCaT Cells
by: Hanon Lee, et al.
Published: (2021-06-01)